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Abstract
Background: Preeclampsia (PE) is a pregnancy-specific syndrome manifested by on-set of hypertension and proteinuria
after 20 weeks of gestation. Abnormal placenta development has been generally accepted as initial cause of the disorder.
Recently, miR-195 was found to be down-regulated in preeclamptic placentas compared with normal pregnant ones,
indicating possible association of this small molecule with placental pathology of preeclampsia. By far the function of miR-
195 in the development of placenta remains unknown.
Methodology/Principal Findings: Bioinformatic assay predicted ActRIIA as one of the targets for miR-195. By using Real-
time PCR, Western blotting and Dual Luciferase Assay, we validated that ActRIIA was the direct target of miR-195 in human
trophoblast cells. Transwell insert invasion assay showed that miR-195 could promote cell invasion in trophoblast cell line,
HTR8/SVneo cells, and the effect could be abrogated by overexpressed ActRIIA. In preeclamptic placenta tissues, pri-miR-
195 and mature miR-195 expressions were down-regulated, whereas ActRIIA level appeared to be increased when
compared with that in gestational-week-matched normal placentas.
Conclusions/Significance: This is the first report on the function of miR-195 in human placental trophoblast cells which
reveals an invasion-promoting effect of the small RNA via repressing ActRIIA. Aberrant expression of miR-195 may
contribute to the occurrence of preeclampsia through interfering with Activin/Nodal signaling mediated by ActRIIA in
human placenta.
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Introduction
MicroRNA is an endogenous ,22 nucleotides non-coding small
RNA with repression of proteins by seed sequence pairing to the
untranslating region (39UTR) of target messenger RNAs [1].
According to the prevailing model, microRNA can direct gene
down-regulation by two posttranscriptional mechanisms: mRNA
cleavage or translational repression. The choice of posttranscrip-
tional mechanism is determined by the identity of target. When
39UTR of target mRNA has perfect complementary to micro-
RNA, it will specify cleavage or it will repress the productive
translation when it has imperfect complementary [2]. Controver-
sially, some microRNAs have been reported that target mRNA
also decreased in despite of imperfect complementary to 39UTR of
target mRNA [3,4]. It is well known that microRNA can regulate
almost one third of human genes [5]. In human, approximately
one third of microRNAs are organized into clusters and it possibly
leads to synergy in biological effects [6]. As microRNAs not only
play important roles in cellular activities including cell pro-
liferation, apoptosis, and cell fate determination [7], but also
participate in many vital processes, such as immune responses,
viral replications [8,9]. The large regulatory network formulated
by microRNAs makes them become the focus of researchers.
Preeclampsia is a syndrome manifested by on-set of hyperten-
sion and proteinuria after 20 weeks of gestation. It is the leading
cause of maternal and fetal morbidity and mortality which has no
good treatment except for delivery of the placenta [10]. In 2007, it
was the first report that preelcampsia was associated with altered
expression of microRNAs in placenta [11]. Later on, several other
groups also published their similar findings in preeclamptic
placentas [12]. It has been generally accepted that abnormal
development of the placenta at early gestation may be the initial
cause of the disease. Therefore, demonstration on the roles of the
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clarifying the pathogenesis of preeclampsia.
MiR-195 is clustered with miR-497 [13] and belongs to miR-15
family [14]. It is well demonstrated that members of a microRNA
family display overlapping, if not identical, roles, for sharing the
same sequence binding to target mRNA [15,16]. In human, miR-
195 and mir-497 were shown potential tumor suppressor gene in
primary peritoneal tumorgenesis [13]. Also, it is reported that
miR-195 serves as tumor suppressor gene in colorectal cancer [17]
and hepatocellular carcinoma [18]. In Xenopus, miR-15/miR-16
regulates early embryonic patterning by targeting Acvr2a (also
named as ActRIIA), which is the type II receptor for ActivinA and
Nodal [19]. When we performed bioinformatic analysis to predict
target genes for miR-195 using four different programs, miRanda,
TargetScan, miRBase, and PicTar, we found ActRIIA is one of
the commonly predicted targets. It is well demonstrated that
Activin/Nodal signaling plays substantial roles in the growth and
differentiation of placental trophoblasts [20,21,22]. Ours and
other’s studies have revealed up-regulation of ActivinA and Nodal
in preeclamptic placenta, indicating involvement of abnormal
ActivinA/Nodal signaling in pathogenesis of preeclampsia.
Based on above evidences, we hypothesized that miR-195 may
participate in the regulation of placental trophoblast cell functions
by targeting ActRIIA. To attest the hypothesis, we checked the
direct binding of miR-195 to ActRIIA mRNA by using luciferase
report assay in human placental trophoblast cell line, HTR8/
Svneo cells. We further detected the influence of miR-195 on
trophoblast cell invasion, and determined the rescue effect of
ActRIIA on miR-195 function. The expression pattern of miR-
195 and ActRIIA in preeclamptic placenta was further examined.
The findings in the present study revealed that miR-195 could
regulate trophoblast cells invasion via repressing ActRIIA protein
expression, and down-regulation of the small molecule may be
involved in the aberrant placenta function which contributes to the
pathology of preeclampsia.
Materials and Methods
Patients
Placenta tissues from 17 normal pregnant women and 15 severe
preeclamptic patients were collected at the Department of
Obstetrics and Gynaecology, Peking University First Hospital,
China. The study was approved by the Research Ethic
Committees in Institute of Zoology, Chinese Academy of Sciences
and in Peking University First Hospital. Written consents were
obtained from all patients. Normal or uncomplicated pregnancy
was defined as a unifetal gestation in a previously normotensive
woman who did not suffer from high blood pressure and
proteinuria during pregnancy, and delivered a healthy neonate
with a weight adequate for gestational age after 37 weeks of
pregnancy. Severe preeclampsia was defined according to the
International Society for the Study of Hypertension in Pregnancy.
In brief, these patients had no history of preexisting or chronic
hypertension, but showed systolic blood pressure $160 mmHg or
diastolic blood pressure $110 mmHg on at least 2 occasions,
accompanying by significant proteinuria (.2 g/24 h or 3+ by
dipstick in two random samples collected at .4 h interval) after 20
weeks of gestation. Those who developed renal disease, transient
hypertension in pregnancy, gestational diabetes, spontaneous
abortion, intrauterine fetal death, fetal chromosomal or congenital
abnormalities or pregnancies conceived by fertility treatment were
excluded from this study. The clinical characteristics of the
patients included in this study were summarized in Table 1.
Sequences and Constructs
The siRNA duplex against human ActRIIA, mature microRNA
mimics for miR-195, miR-195 inhibitor and the scramble control
were designed and purchased from Shanghai GenePharma,
China. The sequences of siRNA and miRNA are shown in
Table 2.
To construct the ActRIIA expressing plasmid (pcDNA4-
ActRIIA), the coding sequence of ActRIIA was amplified and
inserted into pcDNA4.0 vector (Invitrogen, Carlsbad, CA) at the
EcoRI and HindIII restriction sites.
To generate pMIR-REPORT Luciferase plasmids for ActRIIA,
39UTR segments of human ActRIIA mRNA (1694–1890 nt and
2010–2206 nt, Genbank accession no. NM_001616) containing
the two putative miR-195 binding sequences were amplified and
cloned into pMIR-REPORT Luciferase plasmid (Ambion, Austin,
Texas, USA) at the Sac I and Hind III sites. The constructs were
named as BD1-WT and BD2-WT. The mutated pMIR-REPORT
plasmids, which carry site mutations in the 39UTR segments of
human ActRIIA mRNA being complementary to the seed
sequence of miR-195, were generated based on BD1-WT/BD2-
WT plasmids using QuikChange Lightning Site-Directed Muta-
genesis Kit according the manufacture’s instruction (Stratagene,
La Jolla, California, USA). The constructs were named as BD1-
MUT and BD2-MUT. The primers for vectors construction are
shown in Table 3. All the constructs were confirmed by DNA
sequencing.
Culture and Treatment of Trophoblast Cells
The immortalized human trophoblast cell line, HTR8/SVneo,
was a kind gift from Dr. CH Graham at Queen’s University,
Canada [23]. After thawing, the cells were maintained in
RPMI1640 medium (Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum (complete medium), and were
passaged at a ratio of 1:5 every 3 days.
For transient transfection experiments, the cells were seeded in
6-well plates at 2*10
5 cells per well in complete medium. Twenty-
four hours after seeding, miR-195 mimics, inhibitors for miR-195,
specific siRNA for ActRIIA, or pcDNA4/pcDNA4-ActRIIA was
transfected into the cells using lipofectamine 2000 reagent
according to the manufacturer’s instruction (Invitrogen, Carlsbad,
CA). Six hours after transfection, the cells were recovered in the
complete medium. The cells were subjected to further analysis at
certain time as described below.
RNA Extraction and Real-time PCR
Total RNA was extracted using TRIzol reagent (Invitrogen,
Carlsbad, CA) following the manufacturer’s instruction. Two
micrograms of total RNA were reverse-transcribed into cDNA
using oligo (dT) primer (Tiangen Biotech Co, Beijing, China) and
Moloney murine leukemia virus reverse transcriptase (Promega
Corporation, Madison, USA). Reverse transcription of miRNA
was performed according to the instruction of MiRcute MiRNA
First-strand cDNA Synthesis Kit (Tiangen Biotech). In brief,
poly(A) was added to 39end of microRNA, and then oligo(dT)-
universal tag was used as specific primer to generate cDNA for
miRNA.
Real-time PCR was carried out using Applied Biosystems 7500
(Life Technologies, California, U.S.A), and the reaction mixture
contained SYBR Green for cDNA (Takara Biotechnology Co,
Dalian, China) or MiRcute MiRNA Premix for miRNA cDNA
(Tiangen Biotech). The relative expression level of the detected
genes was normalized against the value of corresponding GAPDH
or U6. The sequences of primers are shown in Table 3.
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Whole-cell lysates were prepared as described previously [22].
Protein samples were subjected to SDS-PAGE and transferred to
nitrocellulose membrane. The membranes were incubated with
5% nonfat milk in PBST for 2 hours, and were then incubated
with various primary antibodies overnight at 4uC. After washing in
PBST, the membranes were subsequently incubated with horse-
radish peroxidase-conjugated secondary antibody (Jackson, PA,
USA) for 2 hours. The antibodies used included goat anti-human
ActRIIA (R&D, Minneapolis, USA), rabbit anti-human CCND1
(Abcam, Cambridge, UK), mouse anti-human CCND3 (Cell
Signaling Technology, Beverly, MA, USA), mouse anti-human
Actin (Cell Signaling Technology, Beverly, MA, USA), and mouse
anti-human GAPDH (Ambion, Austin, Texas, USA). Signals were
detected using an Enhanced Chemiluminescence Plus kit (Thermo
Scientific, Rockford, USA) and visualized after exposure to
a Kodak film. The membranes were scanned and signal intensities
were analyzed by the Gel-Pro Analyzer (software version 4.0;
United Bio). The relative densities of the detected molecules were
measured by comparing their densitometry values with those of
GAPDH in the same blot.
Dual Luciferase Assay
HTR8/SVneo cells were plated into 24-well plates at a density
of 5*10
4 cells/well and transfected using Lipofectamine 2000 with
80 ng of pMIR-REPORT plasmid construct, 8 ng of pRL-TK
control vector (encoding Renilla luciferase), and 20 nM of miR-
195 in a final volume of 0.25 ml. Six hours after transfection, the
cells were recovered in complete medium for another 18 hours.
Cells were harvested 48 h post-transfection and luciferase activity
was measured using the Dual-Glo luciferase assay system
according to the manufacturer’s instructions (Promega, Madison,
Wisconsin, USA). Each experiment was repeated for at least three
times with triplicate in each group.
Transwell Insert Invasion Assay
Transwell insert invasion assay was conducted in 24-well fitted
inserts with membranes (8 mm proe size; Costar, Cambridge, MA,
USA) as reported previously [24]. Briefly, 48 hours after trans-
fection, cells were treated with 10 mg/ml mitomycineC for another
2 hours. Then the cells were trypsinized and seeded into transwell
insert pre-coated with 200 mg/ml matrigel (BD Biosciences, USA)
at 1*10
5 cells per insert. The inserts contained RPMI 1640
medium (Invitrogen, Carlsbad, CA) plus 0.5% fetal bovine serum,
and the lower chambers were loaded with RPMI1640 medium
plus 10% fetal bovine serum. Thirty hours later, the cells were
fixed and stained with hematoxylin. Non-invaded cells on the
upper surface of the membrane were removed using a cotton
swab. The number of stained cells at the lower surface of the
membrane was counted in at least 15 randomly selected non-
overlapping fields under light microscope. All experiments were
done in triplicate and the invasion index was expressed as the
percentage of invaded cell number compared with the corre-
sponding control.
MTT Assay
At certain time after seeding, cells were incubated in 1 mg/ml
MTT solution (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazo-
lium bromides; Sigma) for 4 h. After removal of MTT solution,
dimethyl sulfoxide (DMSO) was added, and the absorbance at
a wavelength of 490 nm (reference wavelength 690 nm) was
recorded with Microplate Reader (Bio-Tek Instruments,Inc.). All
experiments were done in triplicate.
Gelatin Zymography
The presence of matrix metalloproteinase (MMP)-2 and
MMP-9 in the media was demonstrated by gelatin zymography.
The harvested culture media were standardized according to the
protein contents of cell lysates. Ten to twenty microliter media
were subjected to 10% SDS-PAGE containing 1 mg/ml gelatin.
After electrophoresis, the gel was washed at room temperature
for 1 h in 2.5% triton X-100, 50 mM Tris -HCl (pH7.5), and
then incubated at 37uC overnight in a buffer containing 150 mM
Table 1. Clinical characteristics of the pregnant women enrolled in this study.
Normal pregnancy(n=17) Preeclampsia(n=15) p-value
Maternal age (years) 29.762.6 27.564.3 0.189
BMI (kg/m
2)
a 24.862.6 24.262.5 0.762
Systolic blood pressure (mmHg) 110.367.7 147.9619.9* ,0.001
Diastolic blood pressure (mmHg) 71.865.6 95.3616.5* ,0.001
50 g GCT (mmol/L)
b 7.260.9 6.660.5 0.121
24 h urine protein (g) 0.0360.06 4.1662.72* ,0.001
Primiparous percentage (%) 71.4 60 NA.
Gestational day at delivery (Day) 27269 262618 0.071
Infant birth weight (g) 35176468 22816774* 0.004
Data are shown as Mean 6SEM, and significant difference between groups was analyzed with one-way ANOVA. *, compared with Normal pregnancy, p,0.05.
a. BMI, body mass index, indicating the weight in kilograms divided by the square of the height in meters.
b. GCT, glucose challenge test.
doi:10.1371/journal.pone.0038875.t001
Table 2. The sequences of siRNA and miRNA.
Mimics Sense Anti-sense
Scramble
control
UUCUCCGAACGUGUCACGUTT ACGUGACACGUUCGGAGAATT
Si-ActRIIA CAAUCAAACUGGUGUUGAATT UUCAACACCAGUUUGAUUGGT
hsa-miR-195UAGCAGCACAGAAAUAUUGGC CAAUAUUUCUGUGCUGCUAUU
Anti-miR-
195
GCCAAUAUUUCUGUGCUGCUA
doi:10.1371/journal.pone.0038875.t002
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subsequently stained with 0.1%(w/v) Coomassie Brilliant Blue R-
250, and destained in 10%(v/v) methanol and 5%(v/v) glacial
acetic acid. The results were analyzed using Quantity One v4.6.2
software (Bio-Rad). All zymography experiments were repeated
at least three times in duplicate.
Statistical Analysis
Data of Transwell insert invasion assay, Dual luciferase assay,
Real-time PCR and Western blotting were reported as Mean 6
SEM according to the results of at least three independently
repeated experiments. The statistical analysis was conducted by
SPSS 17.0 software, and Least Significant Differences (LSD)
method was performed as post-hoc analysis after one-way
ANOVA to detect the significant differences. Differences were
considered significant at P,0.05.
Results
ActRIIA Protein and miR-195 Exhibit Reversed Expression
Pattern in Placentas from Severe Preeclamptic Patients
We compared expression levels of pri-miR-195, miR-195 and
ActRIIA in placentas from 15 severe preeclamptic patients and
17 normal pregnant women. There are no significant differences
in age, body mass index (BMI), glucose tolerance (indicated by
50 g glucose challenge test), infant birth weight, and primiparous
percentage between the normal pregnant and the preeclamptic
women used in this study. As shown in Fig. 1A and 1B, relative
expression of pri-miR-195 and miR-195 in PE placentas was
significantly down-regulated to about 20% and 50%, respective-
ly, of that in normal placentas. ActRIIA mRNA expression was
measured by real-time PCR, and no obviously different relative
level was observed between PE and normal placentas (Fig. 1C).
Western blotting was performed to examine ActRIIA protein
level, and two common samples were included in every blot as
inner control to adjust variations in different blots. Statistic
results showed that the relative density of ActRIIA in PE
placentas was approximately 2-fold higher than that in controls
(Fig. 1D).
Validation of ActRIIA as the Direct Target of miR-195 in
Human Trophoblast Cells
As shown in Fig. 2A and 2B, transfection of miR-195 mimics in
HTR8/SVneo cells resulted in down-regulation of ActRIIA
expression at both mRNA and protein levels. The mRNA and
protein levels of ActRIIA decreased to about 50% and 60% of
controls that were transfected with scramble control.
According to the bioinformatic analysis, miR-195 has two
binding sites in 39UTR of ActRIIA mRNA. The seed sequence of
miR-195 was complementary to the 47–53 nt or 502–508 nt of
39UTR in ActRIIA mRNA. As shown in Fig. 2C, we generated
two luciferase reporter constructs by cloning a 196 bp DNA
fragment including binding site 1 (BD1) or binding site 2 (BD2)of
the 39UTR in human ActRIIA mRNA at downstream of the
firefly luciferase reporter gene (named as BD1-WT and BD2-WT).
A point-mutation was incorporated into the binding sites of
39UTR in ActRIIA gene and the reporter constructs were named
as BD1-MUT and BD2-MUT. HTR8/SVneo cells were trans-
fected with BD1-WT/BD2-WT or BD1-MUT/BD2-MUT re-
porter construct together with miR-195 mimics as well as renilla
luciferase vector (pRL-TK) to be used as reference control.
Relative luciferase activity was monitored 48 h after transfection.
As shown in Fig. 2D, miR-195 mimics could evidently reduce the
relative luciferase activity of BD2-WT construct by about 45%
compared with scramble control, whereas did not show any
suppression on that of BD2-MUT construct. However, miR-195
mimics could not affect the relative luciferase activity of BD1-WT/
BD1-MUT construct. The data strongly validated ActRIIA as
target gene of miR-195 in human trophoblast cells, and the 502–
508 nt of 39UTR in ActRIIA gene was the real binding site for
miR-195.
Effects of miR-195 on Cell Invasion in HTR8/SVneo Cells
To further demonstrate the influence of miR-195 on trophpo-
blast cell behaviors, we examined cell proliferation and invasion in
HTR8/SVneo cells that were transfected with miR-195 or
inhibitor of the small molecule.
As shown in Fig. 3A and D, transfection of mimics or inhibitors
for miR-195 could significantly increase or repress the relative
expression of miR-195 in HTR8/SVneo cells. In these cells,
neither mimics nor inhibitors for miR-195 changed cell viability as
measured by MTT assay (data not shown). Even so, to avoid the
possible influence of cell growth on the result of cell invasion, we
treated the cells with mitomycinC when performing transwell
insert invasion assay. Data revealed that overexpression of miR-
195 in HTR8/SVneo cells evidently promoted cell invasiveness as
well as the activation of MMP-9 and MMP-2, which have been
shown to be the most important MMPs involved in trophoblast
cell invasion (Fig. 3B and C). However, inhibition of miR-195 did
not affect cell invasiveness and MMP-9 or MMP-2 activation. We
assume that the endogenous level of miR-195 in HTR8/SVneo
Table 3. Sequences of the primers used for plasmid construction or real-time PCR.
Product Forward Primer Reverse Primer
ActRIIA BD1 construct GAGCTC ATGGTTGCGCCATCTGTG AAGCTTATGTCCTTCACATCTGTGCT
ActRIIA BD2 construct GAGCTC GGGTAACTTGTTTTTATTGCA AAGCTTGCAACCGTGGAACTGAGGTAT
ActRIIA BD1-MUT construct ACTCTGAACTGGAGCTGGTAAGCTAAAGAAACTGC GCAGTTTCTTTAGCTTACCAGCTCCAGTTCAGAGT
ActRIIA BD2-MUT construct CTTGTGAATGTTTAGTGTGCAGCTGTTCTGTGTACATAAAG CTTTATGTACACAGAACAGCTGCACACTAAACATTCACAAG
ActRIIA expressing plasmid AAGCTTATGGGAGCTGCTGCAAAGTT GGATCCTAGCTTAGCAGCTCCAGTTCA
ActRIIA real-time PCR AGGAGGAAATTGGCCAGCAT GCGTCGTGATCCCAACATTC
GAPDH real-time PCR AAGGTCATCCCTGAGCTGAAC ACGCCTGCTTCACCACCTTCT
has-miR-195 real-time PCR TAGCAGCACAGAAATATTGGC
U6 real-time PCR CGCAAGGATGACACGCAAATTC
doi:10.1371/journal.pone.0038875.t003
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and F).
Overexpression of ActRIIA Attenuates the Invasion-
promoting Effect of miR-195 in HTR8/SVneo Cells
We then tried to figure out whether ActRIIA directly
participated in the invasion-promoting effect of miR-195. Knock-
down of ActRIIA by specific siRNA had similar invasion-
promoting effect in HTR8/SVneo cells (Fig. 3B). We then
performed a ‘‘rescue’’ experiment by transfecting the cells with
miR-195 together with ActRIIA-expressing construct (pcDNA4-
ActRIIA). It was shown that overexpression of ActRIIA could
completely block the invasion-promotion as well as activation of
MMP-9 and MMP-2 caused by miR-195 in HTR8/SVneo cells
(Fig. 4A and B). The data demonstrated that ActRIIA was directly
involved in the invasion-promoting effect of miR-195 in HTR8/
SVneo cells.
MiR-195 did Not Influence CCND1/3 Expression in HTR8/
SVneo Cells
Literature reports revealed that miR-195 could inhibit cell
invasion by inhibiting CCND1 and CCND3 in breast cancer cells
and gliobalstoma cells. We therefore examined CCND1 and
CCND3 expression in HTR8/SVneo cells transfected with miR-
195. As shown in Figure 5, no change in protein levels of CCND1
and CCND3 was observed in HTR8/SVneo cells at 48 h after
miR-195 transfection.
Figure 1. Expression of miR-195 and ActRIIA in placentas derived from severe preeclamptic patients (PE) and gestational-week-
matched normal pregnant women (Control). A, B and C, Quantitative real time PCR to reveal pri-miR-195 (A), mature miR-195 (B) levels and
mRNA expression of ActRIIA (C) in placentas from PE and Control. *, **, compared with Control, p,0.05, p,0.01. D, Western blotting to show protein
levels of ActRIIA in placentas from PE and Control. Upper panel, a typical result of Western blotting. Lower panel, bar chart according to the statistical
analysis based on the result of three independently repeat experiments. *, compared with Control, p,0.05.
doi:10.1371/journal.pone.0038875.g001
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MicroRNAs are newly identified modulators of many compli-
cated signaling pathways involved in various human diseases. In
preeclamptic placentas, several reports demonstrated differentially
expressed microRNAs compared with normal pregnant ones
[11,12,25]. MiR-210 and miR-155 have been subjected to further
functional studies, and data revealed that they are related to
angiogenesis and trophoblast cell invasion/migration [26,27,28].
By far, it remains to be clarified as to how the deregulated
miRNAs participate in the occurrence of preeclampsia.
MiR-195 is one of the differential miRNAs in preeclamptic
placentas reported by Zhu et al. [12]. Here we confirmed the
down-regulation of this small molecule in preeclamptic placentas
from Chinese Han women. By far, functional studies on miR-195
are mainly in cancer, whereas little is known about its role in
placenta. This small molecule attracted our attention for three
reasons: (i) the target prediction result shows that ActRIIA is one of
its possible targets at high value. As we know, ActRIIA is the type
II receptor for Activin and Nodal, and Activin/Nodal signaling
has been shown to play critical roles in modulating functions of
placental trophoblast cells and endothelial cells during pregnancy.
(ii) There are two predicted miR-195 binding sites in 39UTR of
ActRIIA mRNA, and the binding sites are evolutionarily
conserved from amphibians to humans. This suggests that
modulation of ActRIIA by miR-195 may be biologically conserved
during evoluation. (iii) Our previous work and other’s reports
demonstrated overexpression of ActivinA and Nodal in pre-
eclamptic placenta, indicating excessive activation of the signaling
during occurrence of the pregnancy disorder [29]. Our data
revealed that the expression of miR-195 was in an inverse
association with protein level of ActRIIA in severe preeclamptic
placentas, indicating that miR-195 may play roles in the excessive
activation Nodal/ActivinA signaling observed in preeclamptic
placenta.
Figure 2. Validation of ActRIIA as target gene of miR-195 in HTR8/SVneo cells. A. Real-time PCR to reveal change of ActRIIA mRNA level in
HTR8/SVneo cells transfected with scramble siRNA (NC), miR-195 mimics (miR-195) or ActRIIA siRNA (si-ActRIIA). **, compared with NC, P,0.01. B.
Western blot analysis to show change of ActRIIA protein level in HTR8/SVneo cells transfected with NC, miR-195 or si-ActRIIA. Upper panel, typical
results of Western blotting; Lower panel, bar chart representing the statistical analysis by ANOVA according to three independent experiments. The
density of ActRIIA was adjusted by that of GAPDH in the same blot, and the values were presented as Mean6SEM. *, compared with NC, p,0.05. C.
Schematic map for generating luciferase assay constructs. The constructs containing the region complementary to the seed sequence for miR-195 in
39UTR segment of human ActRIIA gene are shown as BD1-WT and BD2-WT, and the mutant constructs are shown as BD1-MUT and BD2-MUT with
asterisks indicating the mutation sites. D. Luciferase assay in HTR8/SVneo cells transfected with BD1-WT, BD2-WT, BD1-MUT or BD2-MUT reporter
construct together with miR-195 mimics (miR-195) or scramble siRNA (NC). The value of corresponding control group (NC) was set as 100, and the
results were presented as Mean6SEM according to three independent experiments. **, compared with corresponding NC, p,0.01.
doi:10.1371/journal.pone.0038875.g002
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38875MiR-195 belongs to miR-15 gene family which includes miR-
15a/b/c, miR-16a/b/c, miR-497 and miR-424. In mamanlian,
only miR-195, miR-497 and miR-424 are expressed [30]. From
literatures of microarray data, miR-195, miR-15b and miR-424
were the three members in miR-15 gene family that exhibited
down-regulation in preeclamptic placenta [12,31]. Functional
studies of these small RNAs in cancer cells revealed that they
mainly participated in regulating cell apoptosis, proliferation and
invasion. For instance, miR-195 could control cell cycle through
targeting cyclin D1, CDK6, and E2F3, and thus suppress the
ability of HCC cells to form colonies in vitro and to develop
tumors in nude mice [18]. MiR-195 could also promote colorectal
cancer cell apoptosis and suppress tumorigenicity by targeting
BCL-2 [17]. Recently, miR-195 and miR-497 were shown to
suppress breast cancer cell proliferation and invasion via targeting
Raf-1 and CCND1 [32]. In glioblastoma cells, miR-195 could
inhibit cell invasion by inhibiting CCND3 and cause cytoplasmic
accumulation of p27 [33]. MiR-15b could regulate cell cycle
progression in glioma cells by targeting cyclin E1 [34]. MiR-424
affected human dermal microvascular ECs (HDMECs) prolifera-
tion via MEK1 and cyclin E1 [35]. Human placental trophoblast
cells have similar properties as tumor cells in the aspects of active
cell proliferation and invasion, although their behaviors are
temporally and spatially restricted during pregnancy. In human
trophoblast cell line, HTR8/SVneo cells, no change in cell
number is observed after miR-195 transfection. This is different
from the observations in hepatocellular carcinoma cells and
colorectal cancer cells [17,18]. Meanwhile, miR-195 shows
strongly invasion-promoting effect in HTR8/SVneo cells, which
is absolutely opposite to the results observed in breast cancer and
glioblastoma cells [32,33]. The two experimentally proved targets
involved in invasion-inhibiting effect of miR-195 in cancer cells,
CCND1 and CCND3, are not influenced by miR-195 in human
trophoblastic HTR8/SVneo cells. Therefore, it is most likely that
miR-195 works in a unique way in human trophoblast cells which
is different from what it does in cancer cells. Considering that the
differentiation status and properties of trophoblast cells vary along
gestation, the roles of miR-195 should be tightly associated with
placental developmental stages. Therefore, further detailed studies
on the localization and expression patterns of miR-195 in human
placenta along the whole gestation are necessary for clarifying its
working mechanisms.
Targets exploration is critical for clarifying the mechanism of
microRNAs. Based on the results of target prediction and
expression pattern of miR-195 in preeclamptic placentas, we
further evaluate whether ActRIIA is functionally involved in
Figure 3. Effect of miR-195 on cell invasion in HTR8/SVneo cells. A and D. The expression of miR-195 in HTR8/SVneo cells transfected with
miR-195 mimics (miR-195), scramble siRNA (NC), miR-195 antigomir (Anti-miR-195) or scramble antigomir (Inhibitor NC) was measured by real time
PCR. The level of miR-195 was adjusted by that of U6, and the relative value was presented as Mean6SEM according to three independent
experiments. *, compared with corresponding NC, p,0.05. B and E. Transwell insert assay to examine cell invasiveness transfected with NC, miR-195,
siRNA for ActRIIA (si-ActRIIA), Inhibitor NC or Anti-miR-195. The value of invasion index in corresponding NC was set as 100, and the results were
presented as Mean6SEM according to three independent experiments. *, compared with corresponding NC, p,0.05. C and F. Gelatin zymography to
measure MMP-2 and MMP-9 productions in cells transfected with miR-195, NC, Inhibitor NC or Anti-miR-195. Upper panels, typical results of gelatin
zymography. Conditioned media of HT1080 cells was included as positive control for zymography. The pro- and active forms of MMP-2 and MMP-9
were separately indicated. Lower panels, bar charts representing the statistical analysis by ANOVA according to three independent experiments. The
densities of pro- and active forms of MMP-2 and MMP-9 were presented as Mean6SEM. *, compared with data in corresponding NC, p,0.05.
doi:10.1371/journal.pone.0038875.g003
Figure 4. ActRIIA rescued the effect of miR-195 on cell invasion in HTR8/SVneo cells. HTR8/SVneo cells were transfected with miR-195 and
ActRIIA alone or in combination, with scramble siRNA (NC) or pcDNA4 vector (pcDNA4) as corresponding negative control. Transwell insert assay was
performed to monitor cell invasiveness (A) and Gelatin zymography was performed to measure MMP-2 and MMP-9 productions (B). The statistical
analysis was carried out by ANOVA according to three independent experiments, and the values were presented as Mean6SEM. *, compared with
corresponding group as indicated, p,0.05.
doi:10.1371/journal.pone.0038875.g004
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evidence prove that ActRIIA is a target of miR-195 in human
trophoblasts. First, ActRIIA expression is suppressed by miR-195
in HTR8/SVneo cells. Second, the regulation of miR-195 on
ActRIIA expression is likely direct, because the luciferase report
construct containing the 39UTR region of ActRIIA mRNA with
the putative miR-195 binding sequence is specifically responsive to
miR-195 overexpression by inhibition on the luciferase activity.
There are two putative conserved binding sites in the 39UTR
region of ActRIIA mRNA, but only one of them is proved to be
directly responsive for miR-195 in human trophoblast cells. Third,
the inhibitory effect of miR-195 on the luciferase activity is
abolished upon mutation in the binding sites paired by the seed
sequence of miR-195. More importantly, ActRIIA could sub-
stantially abrogate the effect of miR-195 on cell invasion and
activation of MMP-2 and MMP-9 in HTR8/SVneo cells. These
findings indubitably indicated that ActRIIA is one of the critical
targets, at least, in mediating the invasion-promoting role of miR-
195 in human trophoblast cells. It is noticeable that miR-15/16
restrict the size of the Spemann’s organizer by targeting ActRIIA
during embryo development in Xenopus [19]. The binding sites in
ActRIIA mRNA for miR-15/16 and miR-195 are conserved,
further suggesting that ActRIIA may be an essential target for
these members of miR-15 family.
In human placenta, ActRIIA is mainly localized in trophoblast
cells at the first and second trimester, and extensive in vascular
endothelium at term pregnancy [36] It’s well known that ActRIIA
is common type II receptor for ActivinA and Nodal. The two
ligands bind to different type I receptor (ALK4 or ALK7) [37],
and cause opposite effect on trophoblast cell invasion [20,29]. The
invasion-promoting effect of miR-195 observed in HTR8/SVneo
cells most likely results from interference on Nodal signaling
mediated by suppressed expression of ActRIIA, as it has been
shown that Nodal inhibits, whereas ActivinA promotes trophoblast
cell invasion. Our previous study has demonstrated up-regulation
of Nodal expression in PE placenta [29]. The increase of ActRIIA
receptor resulting from, at least in part, lowered miR-195 in PE
placenta will lead to further augment of Nodal signaling and
therefore inhibition on trophoblast cell invasion. Abnormal
placental development, especially shallow invasion of trophoblast
cells into decidual stroma and spiral arteries at early gestation has
been generally accepted as the causal factor for the complex
syndrome [38]. Our data regarding the expression pattern of miR-
195 and ActRIIA in PE placenta as well as their regulation on
trophoblast cell invasion are likely indicating the way whereby
miR-195 participates in the pathogenesis of PE.
The mechanism of miR-195 down-regulation in preeclamptic
placenta remains unknown. High frequency of loss of heterozy-
gosity has been found on chromosome 17p13.1 where miR-195
located, which is implicated to play important roles in the
pathogenesis of many types of tumors [39]. Recently, the
methylation state of CpG islands upstream of the miR-195/497
gene was found to be responsible for the down-regulation of both
miRNAs in breast cancer [32]. Our finding of lowered expression
of pri-miR-195 in PE placenta strongly indicates the aberrant
transcription of this small RNA during the pathological process.
Whether allelic loss and promoter hypermethylation can account
for the reduced miR-195 expression in PE placentas needs further
investigation.
This study extends our knowledge on the functions of miR-195
in human placenta. The specifically aberrant regulation on miR-
195 expression may contribute to the occurrence of preeclampsia
through destroying physiological role of Nodal signaling in
trophoblast cells. Given that a single microRNA can target many
genes, we believe that miR-195 also has multiple targets. It will
greatly help us to better understand the mechanism of miR-195 in
Figure 5. Effect of miR-195 on protein expression of CCND1 and CCND3 in HTR8/SVneo cells. A. Real-time PCR to reveal miR-195 level in
HTR8/SVneo cells transfected with scramble siRNA (NC) or miR-195 mimics (miR-195). **, compared with NC, p,0.01. B. Western blot analysis to show
change of CCND1 and CCND3 protein level in HTR8/SVneo cells transfected with NC or miR-195. Upper panels, typical results of Western blotting;
Lower panels, bar charts representing the statistical analysis by ANOVA according to three independent experiments. The densities of CCND1 and
CCND3 were adjusted by that of Actin in the same blot, and the values were presented as Mean6SEM.
doi:10.1371/journal.pone.0038875.g005
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addition, a precise expression timing and localization of the small
RNA and its target genes during placenta development need to be
taken into account to identify their working mechanisms.
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